Print Page   |   Sign In   |   Join!
NWPSHP 2019 Spring CE Day
Tell a Friend About This EventTell a Friend
 

5/11/2019
When: Saturday, May 11, 2019
8:00 AM - 12:30 PM
Where: Lincoln Education Center Magee-Womens Hospital at UPMC Hamot
118 E. 2nd St
Erie, Pennsylvania  16507
United States
Contact: Angela Shick

« Go to Upcoming Event List  

2019 NWPSHP Spring CE Day

 

Check-in: 8:00 am – 8:15 am

CE Day: 8:15 am – 12:15 pm

Closing Remarks: 12:15 pm – 12:30 pm

 

 

Free to NWPSHP Members

$20 Fee for Non-Members

 

Pre-registration is required

 

Please register by emailing nwpshp@gmail.com by Friday, May 3, 2019

 

Agenda
 8:00 - 8:15 AM Check-In and Breakfast 
 8:15 - 8:20 AM

Welcome and Announcements 

Paul Green, Pharm.D., MHA, BCPS
System Director of Pharmacy, Upper Allegheny Health System
NWPSHP President

 8:20 - 9:20 AM

Clearing the Smoke: Medical Cannabis

Elizabeth Harrington, Pharm.D.
Dispensary Pharmacist, RISE Erie

 9:20 - 9:30 AM Break
 9:30 - 12:15 PM Resident Presentations (15 minutes each)
 

A New Brew: 2019 Updates to the Beer’s Criteria

Elizabeth Steadman, Pharm.D.
PGY2 Geriatric Pharmacy Resident
LECOM / Millcreek Community Hospital

Acute Respiratory Distress Syndrome: iNO versus iEPO

Christine Zdaniewski, Pharm.D.
PGY1 Pharmacy Resident
UPMC Hamot

 

Venous Thromboembolism Prophylaxis in Ambulatory Cancer Patients

Kylee Gross, Pharm.D.
PGY1 Pharmacy Resident
LECOM / Millcreek Community Hospital

Baloxavir marboxil for Influenza

Aubrie Gaydosh, Pharm.D.
PGY1 Pharmacy Resident
Erie VA Medical Center

 

Use of omadacycline in the treatment of community-acquired pneumonia 

Nicolas Lombardo, Pharm.D.
PGY1 Pharmacy Resident
LECOM / Millcreek Community Hospital

The Emerging Role of Pimavanserin in the Management of Parkinson’s-Related Psychosis and the Potential in Dementia-Related Psychosis 

Danielle Distefano, Pharm.D.
PGY1 Pharmacy Resident
Erie VA Medical Center

 

Esketamine in Treatment-Resistant Depression

Megan Walker, Pharm.D.
PGY1 Pharmacy Resident
LECOM / Millcreek Community Hospital

Impact of intensive care unit stay on post-discharge opioid requirements

Lauren Bobby, Pharm.D.
PGY1 Pharmacy Resident
St. Vincent Hospital
Precepted by Justine Russell, PharmD, BCPS

 

What’s the Difference? Serotonin Syndrome vs. Neuroleptic Malignant Syndrome

Meghan Martin, Pharm.D.
PGY1 Pharmacy Resident
UPMC Hamot

Anti-thrombotic therapy post percutaneous coronary intervention in patients with atrial fibrillation

Maria Patnella, Pharm.D.
PGY1 Pharmacy Resident
St. Vincent Hospital
Precepted by Jenna Young, PharmD, BCPS

 

HCAP Review:  A Breath of Fresh Air

Ariel Korlinchak, Pharm.D.
PGY1 Pharmacy Resident
UPMC Hamot

 
 12:15 - 12:30 PM  Announcements / Officer Nominations

 

Learning Objectives - Pharmacists
  1. Discuss:
    1. the endocannabinoid system
    2. the pharmacology of cannabis
    3. the Pennsylvania Medical Marijuana Program
  2. Identify major changes to the Beer’s Criteria outlined in the American Geriatrics Society (AGS) 2019 Update
  3. Interpret new clinical trial publications regarding VTE prophylaxis in ambulatory cancer patients and apply results to decision making in clinical practice
  4. Discuss omadacycline’s place in therapy for the treatment of community-acquired pneumonia 
  5. Discuss the use of esketamine in treatment-resistant depression including dosing, warnings, and side effects
  6. Identify the differences between serotonin syndrome and neuroleptic malignant syndrome
  7. Assess available rationale for the removal of healthcare-associated pneumonia (HCAP) from the 2016 hospital-acquired pneumonia (HAP) / ventilation-associated pneumonia (VAP) guidelines
  8. List advantages and disadvantages for both inhaled nitric oxide and inhaled epoprostenol in the treatment of acute respiratory distress syndrome (ARDS)
  9. Describe the MOA, dosing, warnings, and side effects for baloxavir marboxil
  10. Compare baloxavir marboxil to neuraminidase inhibitors (oseltamivir, zanamivir, and peramivir)
  11. Describe the mechanism of action of pimavanserin as it relates to Parkinson’s-related psychosis
  12. Discuss the evidence of pimavanserin in trial for the safety and efficacy in Dementia-related psychosis
  13. Summarize the available literature regarding the impact of an ICU admission on post-discharge opioid requirements
  14. Describe evidence-based anti-thrombotic regimens for patients with atrial fibrillation post percutaneous coronary intervention 
Learning Objectives - Technicians
  1. Discuss:
    1. how medical marijuana works
    2. what medical marijuana can be used for
    3. the Pennsylvania Medical Marijuana Program
  2. Identify uses for the Beer’s Criteria outlined in the American Geriatrics Society (AGS) 2019 Update
  3. State the indications for VTE prophylaxis in ambulatory cancer patients
  4. Discuss uses for omadacycline in patients with pneumonia
  5.  Discuss dosing, administration, and monitoring for esketamine
  6. Identify the differences between serotonin syndrome and neuroleptic malignant syndrome
  7. Differentiate between HCAP, HAP, and VAP
  8. List advantages and disadvantages for the preparation of both inhaled nitric oxide and inhaled epoprostenol
  9. Describe the indication, dosing, warnings, and side effects for baloxavir marboxil
  10. Describe the indication and monitoring of pimavanserin as it relates to Parkinson’s-related psychosis
  11. Discuss how ICU admissions impact opioid requirements on discharge
  12. Describe risks and monitoring regarding anti-thrombotic regimens for patients with atrial fibrillation post percutaneous coronary intervention
Target Audience:  Pharmacists and Pharmacy Technicians

ACPE Accreditation Statement – For Pharmacists & Technicians

The University of Pittsburgh Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education. 

The assigned universal program number(s): 0481-0000-19-101-L04-P and 0481-0000-19-101-L04-T

This knowledge-based activity provides 3.75 contact hours (0.375 CEU) of General Pharmacy continuing education credit. Credit will be awarded upon successful completion of this program including: attending the full session, completing and submitting a self-graded post-test with an 80% pass rate, completing and submitting a program evaluation and CPE Verification and Designation Form. 

Faculty Disclosure:

Faculty for this activity have been required to disclose all relationships with any proprietary entity producing health care goods or services, with the exemption of non-profit or government organizations and non-health care related companies.  

No relevant financial relationships with commercial entities were disclosed by any of the featured speakers. 

Membership Management Software Powered by YourMembership  ::  Legal